 Autologous bone marrow transplantation high-risk remission T-lineage acute lymphoblastic leukemia immunotoxins marrow purging Fourteen patients high-risk T-lineage acute lymphoblastic leukemia complete remission underwent autologous bone marrow transplantation BMT attempt residual disease burden combined immunochemotherapy protocol cocktail immunotoxins T-lineage differentiation antigens combination vitro active cyclophosphamide congener autografts high dose pretransplant radiochemotherapy effective purging autografts patients median months range months post BMT patients alive disease free months BMT novel quantitative minimal residual disease MRD detection assay fluorescence multiparameter flow cytometry cell leukemic progenitor cell LPC remission bone marrow BM T-lineage ALL patients presence residual LPCs high numbers residual LPC remission BM BMT poor prognostic indicator first evidence biologic significance clinical value vitro T-lineage ALL LPC assays median value residual leukemia burden BMT mononuclear cells MNC LPC Patients residual leukemia burden median value outlook free relapse autologous BMT patients leukemia burden Mantel-Cox comparison log efficacy purging numbers LPC purged autografts estimated numbers reinfused LPC probability disease-free survival DFS results primary reason recurrence leukemia inefficient pretransplant radiochemotherapy inefficient purging autografts